Minimally invasive surgery (MIS) is a modern technique that enables surgeons to use endoscopic procedures to address diverse issues. The instruments used during minimally invasive surgery (MIS) are small, hence the incisions are smaller than in a traditional open surgery.
Additionally, the technology is proving its efficiency in treatment while performing complex surgeries thus driving the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market during the forecast period.
The global minimally invasive surgery (MIS) market (laparoscopic surgery, robotic surgery, EMR, ESD) was valued at US$ 1.1 Bn in 2017 and is projected to expand at a CAGR of 9.2% from 2018 to 2026. The endoscopic mucosal resection segment dominated the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market in 2017.
Multitude of factors including technological advancements driving the global Minimally Invasive Surgery (MIS) Market (laparoscopic surgery, robotic surgery, EMR, ESD)
Rise in prevalence of chronic diseases, technological advancements, and increase in patient awareness and health care expenditure are driving the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market. Moreover, surge in the need of treatment of complex diseases drive the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market.
The robotic surgery segment is expected to be the fastest growing segment of the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market during the forecast period. The segment has witnessed strong growth owing to increase in demand for precise and technological advanced surgery. This in turn is propelling the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market. The highly fragmented nature of the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market has prompted market players to shift focus toward relatively niche segments such as robotic surgery.
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=66893
Global Minimally Invasive Surgery (MIS) Market (laparoscopic surgery, robotic surgery, EMR, ESD): Segmentation Overview
The global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market has been segmented based on procedure, indication, and region. In terms of procedure, the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market has been classified into laparoscopic surgery, robotic surgery, endoscopic mucosal resection, and endoscopic sub-mucosal dissection.
Based on indication, the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market has been categorized into gastric cancer, Barrett’s esophagus, small intestine (duodenum) cancer, colorectal cancer, esophageal cancer, and others.
The colorectal cancer segment is projected to account for major share of the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market due to increase in incidence of targeted diseases across various regions, rise in prevalence of lifestyle diseases, and ongoing technological advancements.
Regional Outlook
In terms of region, North America dominated the global M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market in 2017, owing to a highly developed health care sector, increase in awareness among health care providers about minimally invasive surgery, and continuous evolution of products.
North America is also an attractive market in terms of revenue. Rise in government initiatives & laws and increase in population drive the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market in the region.
Technological advancements and increase in adoption of advanced surgery devices are expected to propel the M.I.S. (laparoscopic surgery, robotic surgery, EMR, ESD) market in Asia Pacific, Latin America, and Middle East & Africa during the forecast period.
Comments
Post a Comment